(Abst.) Recurrence of disease activity after ocrelizumab discontinuation in MS on: October 07, 2024, 09:25:39 am #1 This was a small study but it indicates that some people might have worsening MS if they stop taking Ocrevus....From PubMed (October 7, 2024)--"The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis": The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosis - PubMed We found focal inflammation after discontinuation of OCR in 4 (9.8 %) of the RRMS patients, of which 1 was radiologically confirmed. Our observations highlight that recurrence of focal inflammation... PubMed · pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
(Abst.) Discontinuation of ocrelizumab in MS: Reoccurence of disease activity Reply #1 on: January 21, 2026, 08:53:17 pm #2 Another study on this topic.From PubMed (January 21, 2026)--"Discontinuation of ocrelizumab in multiple sclerosis: Reoccurence of disease activity": Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity - PubMed For stable pwMS, ocrelizumab discontinuation after about 30 months on-treatment appears safe short-term, though vigilant monitoring is warranted beyond 2 years off-treatment due to potential delaye... PubMed · pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
